anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
atai · pitchdeck

ATAI | Investor Presentation Deck | 30 slides

30 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

ATAI | Investor Presentation Deck | 30 slides

atai · 2023-04
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 23 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 13 hits
— 0/2 slides
50% 1/2 slides 50% 1/2 slides 100% 2/2 slides · 3 hits 100% 2/2 slides · 4 hits Solution 3 slides 100% 3/3 slides 100% 3/3 slides · 16 hits
— 0/3 slides
66.7% 2/3 slides 100% 3/3 slides 100% 3/3 slides · 5 hits 100% 3/3 slides Traction 16 slides 100% 16/16 slides 100% 16/16 slides · 81 hits
— 0/16 slides
50% 8/16 slides · 10 hits 56.3% 9/16 slides 100% 16/16 slides · 17 hits 100% 16/16 slides · 17 hits Roadmap 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits
— 0/2 slides
50% 1/2 slides 100% 2/2 slides 100% 2/2 slides · 4 hits 100% 2/2 slides

Slide inventory

30
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
Includes a footer note regarding the update date of March 24th, 2023.front_matter
Open slide detail
03
The slide uses a numbered list to present five key pillars of the company's value proposition.summarize
Open slide detailLoop · Golden Circle
04
The slide uses a hierarchical structure to connect a high-level objective to three specific strategic pillars.present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
05
The slide uses a Gantt-style visualization to show drug development progress.plan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
06
The slide uses a timeline format to communicate both past achievements and future R&D milestones.plan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
07
transition
Open slide detailLoop · Golden Circle
08
Uses a timeline-style vertical flow to represent the 'need' metrics.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
09
Includes a quote from Keith Nuechterlein, Ph.D. regarding the clinical significance of the Symbol Coding results.show_traction
Open slide detailBeat · ProblemLoop · Cost Of Inaction
10
The slide uses a vertical process flow to show the progression of clinical trials and data validation.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
11
The slide highlights the 'inverted-U' dose-response curve, a key pharmacological characteristic for this drug candidate.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
12
The slide highlights that lower doses of RL-007 (40 or 80 mg TID) show statistically significant improvements compared to placebo in cognitive endpoints.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
13
The slide uses a standard clinical trial flow diagram to illustrate the study methodology.plan_implementation
Open slide detailBeat · TractionLoop · Golden Circle
14
transition
Open slide detailBeat · TractionLoop · Golden Circle
15
The slide uses a split-layout: left side defines the condition and market size, right side highlights the 'unaddressed need' (treatment gap, comorbidity, and laframe_problem
Open slide detailBeat · TractionLoop · Golden Circle
16
The slide uses a split-layout with a left-hand summary table and a right-hand clinical data visualization.summarize
Open slide detailBeat · TractionLoop · Golden Circle
17
The slide uses a numbered list to highlight key safety findings alongside a detailed data table.analyze_data
Open slide detailBeat · TractionLoop · Golden Circle
18
The slide uses topographical brain maps to visualize EEG data changes.analyze_data
Open slide detailBeat · TractionLoop · Golden Circle
19
The chart displays pharmacodynamic data from a clinical trial, specifically EEG beta power changes relative to pre-dose levels.analyze_data
Open slide detailBeat · TractionLoop · Golden Circle
20
The slide uses a checkmark matrix to highlight the competitive advantage of the drug candidate.compare_peers
Open slide detailBeat · TractionLoop · Golden Circle
21
transition
Open slide detailBeat · TractionLoop · Golden Circle
22
The slide uses a dual-column layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' using a vertical process/listframe_problem
Open slide detailBeat · TractionLoop · Golden Circle
23
The slide uses a line chart to show MADRS score changes over 12 weeks across three dosage groups.show_traction
Open slide detailBeat · TractionLoop · Golden Circle
24
The slide uses a timeline-based process diagram to illustrate clinical trial protocols.plan_implementation
Open slide detailBeat · TractionLoop · Golden Circle
25
Includes a summary table on the left and a line chart showing clinical trial results on the right.present_solution
Open slide detailLoop · Golden Circle
26
transition
Open slide detailLoop · Golden Circle
27
Uses a process-style timeline to list key statistics about the OUD crisis.frame_problem
Open slide detailLoop · Golden Circle
28
Includes a line chart showing HCQN subscale reduction over time and a two-stage trial design diagram.present_solution
Open slide detailLoop · Golden Circle
29
The table highlights DMX-1002's unique profile compared to standard Medication Assisted Therapy and Withdrawal Support.compare_peers
Open slide detailLoop · Golden Circle
30
inspire_vision
Open slide detailLoop · Golden Circle